FDA REFORM BILL COULD SEE SENATE FLOOR ACTION BY APRIL, DOLE TELLS DEVICE REPS; COMMISSIONER KESSLER TO TESTIFY AT LABOR COMMITTEE HEARING FEB. 21
This article was originally published in The Gray Sheet
Executive Summary
Senate Majority Leader Robert Dole (R-Kan.) expressed optimism that FDA reform legislation could reach the Senate floor by April during an hour-long meeting with medical product manufacturers on Feb. 13 in Manchester, New Hampshire.